Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Jim Bishop who wrote (102561)	3/22/2002 1:57:52 PM
From: The Osprey	Read Replies (1) \| Respond to of 150070

More like Heat Jim not fire...Raids rumoured to be occuring at nite and HRZG by federalis

To: Jim Bishop who wrote (102561)	3/22/2002 5:08:47 PM
From: StocksDATsoar	Respond to of 150070

COMTEX) B: T-19 Inc. Proud to Announce Tubercin Inventor and Scientific B: T-19 Inc. Proud to Announce Tubercin Inventor and Scientific Advisor Dr. Tai-Ho Chung Ph.D. M.D. Has Been Reappointed World Health Organization Immunological Research Director HONOLULU, Mar 22, 2002 (BW HealthWire) -- T-19 Incorporated is proud to announce that Tubercin inventor and scientific advisor Dr. Tai-Ho Chung Ph.D. M.D. has been reappointed Director of the World Health Organization (WHO) Collaborating Centre for Immunological Research on the Prevention and Control of Viral Hepatitis and its Related Disease. T-19 has entered into a Letter of Intent to be acquired by LCS Golf Inc (OTCBB:LCSG). LCS Golf President Michael Mitchell M.D. says, "This appointment furthers the credibility and our excitement concerning this pending acquisition." Over two thousand stage 3 and 4 cancer patients have been treated with an injectable version of Tubercin under strict clinical settings in South Korea at the oldest and very prestigious university hospital, Kyungpook National University Medical School, in Taegu, Korea. Today approximately 40% of these 2000 terminal Cancer patients were positively impacted and a significant number has remained cancer free within a 20 year duration. Dr. Tai-Ho Chung, the inventor of Tubercin T-5, has published his findings over the last seventeen years in Korean Medical Journals. Dr. Tai-Ho Chung was the former Medical School dean and is currently the Director of the World Health Organization (WHO) Collaborating Centre for Immunological Research on the Prevention and Control of Viral Hepatitis and its Related Disease situated at the Kyungpook National University, Taegu, Korea. T-19 Incorporated is preparing a version of Tubercin called T-19 which is to be ingested as a nasal spray. More information can be found at: tubercin.com. Disclaimer: Statements, which are not historical facts, are forward-looking statements. The Company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company's public announcements. CONTACT: T-19 Incorporated, Honolulu Eric Schopfer, 866/523-5800 URL: businesswire.com Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. Copyright (C) 2002 Business Wire. All rights reserved. -0- KEYWORD: FLORIDA HAWAII KOREA INTERNATIONAL ASIA PACIFIC INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL MERGERS/ACQ PRODUCT SOURCE: LCS GOLF, INC. * end of story *